Requires the Secretary of Health and Human Services to issue best-practice guidance within 12 months to State Medicaid and CHIP agencies, the Indian Health Service, Indian Tribes and tribal organizations, and Urban Indian organizations on preventing, screening, testing, treating, and educating about syphilis and congenital syphilis. The guidance must address third‑trimester and delivery screening, telehealth, patient education, and timely treatment. Also requires the Secretary to report to Congress within two years on how those best practices were implemented. The law is focused on reducing rising syphilis rates and preventing congenital syphilis by improving screening and care during pregnancy.
In 2023 there were 209,253 cases of syphilis in the United States, the highest number since 1950, representing an 80 percent increase since 2018 and continuing a decades-long upward trend.
Untreated syphilis can seriously damage the heart and brain and can cause blindness, deafness, and paralysis.
The rise in syphilis cases is driving an increase in congenital syphilis: more than 3,882 cases, a 3 percent increase from 2022, resulting in 252 stillbirths and 27 infant deaths; these congenital cases are more than 10 times the number diagnosed in 2012.
When syphilis is transmitted during pregnancy, it can cause miscarriage, lifelong medical issues, and infant death; at birth babies can have neonatal death, meningitis, anemia, and spleen and liver problems; if not treated, congenital syphilis can cause bone and joint problems, vision and hearing problems, nervous system issues, and developmental delays.
High rates of congenital syphilis are often due to lack of timely testing or inadequate treatment during pregnancy; timely testing and treatment during pregnancy might prevent almost 90 percent of congenital syphilis cases.
Primary affected groups are pregnant people and newborns: the guidance aims to increase prenatal screening and ensure timely treatment to prevent congenital syphilis and reduce pregnancy loss or severe infant illness. State Medicaid and CHIP agencies and Indian health systems are primary institutional targets; they receive the guidance and are expected to consider adopting recommended practices. Health care providers (prenatal clinicians, obstetricians, midwives, public health clinics) will be expected to use the guidance to adjust screening and treatment workflows, including third‑trimester and delivery testing where indicated and use of telehealth for follow-up. Public health programs may see increased testing, case detection, and treatment demand; without dedicated new funding, some providers and clinics—especially under-resourced ones—may need to reallocate resources to implement recommendations. Tribal governments and Indian Health Service facilities are directly addressed, which may improve access and consistency of care for American Indian/Alaska Native pregnant people. The required report to Congress will show how recipients implemented best practices and could prompt further federal or state action, guidance refinement, or funding to support implementation.
Last progress June 10, 2025 (8 months ago)
Introduced on June 10, 2025 by Martin Heinrich
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Updated 2 days ago
Last progress June 10, 2025 (8 months ago)